Lv72
4950 积分 2023-03-29 加入
[China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)]
3个月前
已完结
Evolution of small cell lung cancer tumor mutation: from molecular mechanisms to novel viewpoints
6个月前
已完结
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors
6个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
7个月前
已完结
Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
7个月前
已完结
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
7个月前
已完结
Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection
7个月前
已完结
Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
7个月前
已完结
Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma
7个月前
已完结
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
8个月前
已完结
皖公网安备34019202002308
